°¢Ë¾Æ¥ÁÖÀµ°±ËáÑÎ,aspirin-DL-lysineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ù¿ÆÊÖÊõ,PaediatricÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÉÈÅËØ-¦Ë2,IFN-¦Ë2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Æ¥¶àĪµÂ¿Ú·þÒº,PIDOTOMODÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼ÙÐÔÈ©¹Ìͪ¼õÉÙÖ¢,pseudohypoaldosteronismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »¹¶û½ð,HuanerjinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÏÏ¢ºóѪÇå,postasphyxial-serumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔÙ¸ÉÔ¤,re-interventionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Î²¿Òô,raleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µÍÁ×ËáøѪ֢,hypophosphatasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃâÒßÖ²¡»úÖÆ,immunopathogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±ÇÈûʽÆøµÀ³ÖÐøÕýѹͨÆø,NCPAPÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö§Ô­ÌåIgM¿¹Ìå,Mp-IgMÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÉú¶ùºôÎü¾½ÆÈ×ÛºÏÖ¢,NRDSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼ÙÐÔ¼××´ÅÔÏÙ»úÄܼõÍËÖ¢,pseudohypoparathyroidism(PHP)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÉú´óÊó,Neonatal RatÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾ªØʳÖÐø״̬,Status convulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½Ç»¯Ï¸°ûÉú³¤Òò×Ó,keratinocyte growth factorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« IgGÑÇÐÍ,IgG subclassÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àÔàÆ÷¹¦ÄÜÕÏ°­×ÛºÏÖ¢,Multiple organ dysfunction syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Î÷Ñó,the WestÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃâÒß·´Ó¦ÐÔÒȵºËØ,Immunoreactive insulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÉúÓ¤¶ù,Newborn infantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔ¼²²¡/Õï¶Ï,Brain Diseases/DiagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µçѹÃſؼØÀë×ÓͨµÀ,voltage-gated potassium channelsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼à²âÓë·ÖÎö,Surveillance and analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­ëÄPÎïÖÊ,Substance PÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎæÈÈ×ÛºÏÕ÷,muggy syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Õæ¾ú·ÎÑ×,fungus pneumoniaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á¼ÐÔ¼Ò×åÐÔÓ¤¶ù¾ªØÊ,Benign familial infantile convulsionsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΣÖز¡ÀýÆÀ·Ö,critical illness scoreÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³ÖÐø¾²ÂöµÎ×¢,Continuous infusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« С¶ù¾ªØÊ,Infantile convulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΣÖضù,Critically ill childrenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºôÎüµÀ×èÈû,airway obstructionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼¡ËáÁ×Ëἤøͬ¹¤Ã¸,creatine kinase MBÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ì춬°±Ëá°±»ùתÒÆøÀà/·ÖÎö,Aspartate aminotransferases/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΣÖØ»¼¶ù,critical childrenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾²Âö×¢Éä±ûÖÖÇòµ°°×,intravenous immunoglobulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á¬ÐøÉöÌæ´úÖÎÁÆ,continuous renal replacement therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼ø±ðÕï¶ÏÖ¸±ê,differential diagnostic indexesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÉú¶ù¾ªØÊ,Neonatal seizuresÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« È«ÃæÐÔñ²üê°éÈÈÐÔ¾ªØʸ½¼ÓÖ¢,generalized epilepsy with febrile seizures plusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍËÈÈÌù,cooling pasteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾ªØÊÐÔÄÔËðÉË,convulsion-induced brain injuryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ßÉøѪ֢,Plasma hyperosmolalityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹Ü»îÐÔÒ©,vasoactive drugÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éàϵηþ,dropping under tongueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ùͯ¸ßÈÈ,childnen high feverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ÉÈÜÐÔÖ×Áö»µËÀÒò×ÓÊÜÌå¢ñ,Soluble tumor necrosis factor receptor-¢ñÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊîÈÈÖ¢,summer feverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶îÒ¶ÄÔ»Ø,Frontal lobe gyrusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±»¶¯Ä¤ÌØÐÔ,passive membrane propertiesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢Á¿ÑªÌÇ,microamount Blood GlucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« С¶ùΣÖز¡ÀýÆÀ·Ö,The pediatric critical illness scoringÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈȾªØÊ,febrile convulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´ÙÑ×Ö¢/¿¹Ñ×Ö¢,Pro-inflammatory / Anti-inflammatoryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µçѹÃÅ¿ØÄÆͨµÀ¦Â1Ñǵ¥Î»,voltage-gated sodium channel ¦Â1 subunitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÆøµÀÎü³öÎï,tracheal aspiratesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼×ÐÍH1N1Á÷¸ÐΣÖØÖ¢,severe influenza A(H1N1)virus infectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼ÒÍ¥Ô¤·À,family preventionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ù¿ÆΣÖØÖ¢,pediatric intensive caseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ðļ¡¼¡¸Æµ°°×-I,cardial troponin IÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 賦Ëðº¦,gastrointestinal damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θ³¦Î¹Ñø,gastrointestinal feedingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·´¸´¸ßÈȾªØÊ,recurrent febrile seizuresÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ŧ¶¾Ö¢×ÛºÏÕ÷/øѧ,Sepsis Syndrome/enzymologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·¢Óý³Ù»º,developmental delayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ùͯÖØÖ¢¼à»¤²¡·¿,Pediatric intensive care unit(PICU)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃÀÁÖ»ìÐüÒº,high feverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ßÌǸßÉøѪ֢,Hyperglycemic hyperosmolarityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿É¿Ø¹ÄÅÝʽÕýѹºôÎüÖ§³Ö×°ÖÃ,Bubble positive pressure breathing deviceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ȱÑõȱѪÐÔÄÔËðÉË,hypoxic-ischemic brain damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÏÖªÉñ¾­¿Æѧ,cognitive neuroscienceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ì¥·àÎüÈë×ÛºÏÕ÷,meconium aspiration syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÉú¶ùÆÆÉË·ç,Neonatal tetanusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÂÕæѵÁ·,simulation trainingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¨ºìËØÄÔ²¡,Bilirubin encephalopathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¿Ñõ,pure oxygenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈË¿ÚÖÊÁ¿,Population qualityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±½±û°±ËáôÇ»¯Ã¸,phenylalanine hydroxylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ì¥·àÎüÈë,meconium aspirationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ôç²ú¶ùÊÓÍøĤ²¡,Retinopathy of prematurityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³±ÆøºôÎü,tidal breathingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ìý¾õ,auditoryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʧƥÅ为²¨,mismatch negativityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔѪÁ÷ËÙ¶È,cerebral blood flow velocityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÜÀíÄ£¿é,management moduleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÉú¶ùȱÑõȱѪÐÔÄÔ²¡,Hypoxic-ischemic encephalopathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈËѪÇåµ°°×,human serum albuminÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼ª°²ÊÐ,Ji an CityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÈÌìÐÔ¼××´ÏÙ¹¦ÄܼõÍËÖ¢,Congenital hypothyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò»Ñõ»¯µª/ѪҺ,Nitric oxide/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒõÀë×Ó¼ä϶,Anion gapÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÈÌìÐÔ¼××´ÏÙ¹¦ÄܵÍÏÂ,congenital hypothyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ßƵÕñµ´,high frequency oscillationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­±£»¤¼Á,neuroprotective agentsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Î±íÃæ»îÐÔ¼Á,Pulmonary surfactantsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔËðÉË/ÖÎÁÆ,brain injuries/THÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÎÑ××ÛºÏÕ÷,hepatitis syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
 ÉÏÒ»Ò³ 1 2 3 4 5 6 7 8 ÉÏÒ»Ò³